102 Then again, several teams are advocating to the incorporation of novel markers, such as a complex karyotype55 or epigenetic subsets, 27,28 into medical apply. These novel prognostic and/or predictive types will need to be validated in cohorts of sufferers addressed with focused brokers. ?????